Moderna announced Monday that it plans to release a combined Covid-flu-RSV booster vaccine in late 2023, in the hopes that a combined vaccination will motivate consumers to obtain an annual injection.
Before 2024, a single vaccination for Covid-19, influenza, and respiratory syncytial virus (RSV), a common virus that causes the common cold but can be more dangerous in newborns and the elderly, could be available.
“Best-case scenario will be the fall of ’23,” Moderna chief executive Stephane Bancel told a virtual World Economic Forum roundtable session.
“I don’t think it would happen in every country, but we believe it’s possible to happen in some countries next year.
“Our goal is to be able to have a single annual booster so that we don’t have compliance issues where people don’t want to get two to three shots a winter, but to get one dose.”
